Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Per Thor Straten

Showing results (131-140 of 171) with videos related to

Pageof 18
Sort By:
Oncoimmunology|July 14, 2025
ProS1-MerTK signaling in CD4 T cells: implications for TIL expansion and functionalityAnnina Kurzay, Sara Fresnillo Saló, Anne Rahbech, et al.
Oncoimmunology|May 8, 2015
Tryptophan 2,3-dioxygenase (TDO)-reactive T cells differ in their functional characteristics in health and cancerMads Duus Hjortsø, Stine Kiaer Larsen, Per Kongsted, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 24, 2016
Long-Lasting Complete Responses in Patients with Metastatic Melanoma after Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes and an Attenuated IL2 RegimenRikke Andersen, Marco Donia, Eva Ellebaek, et al.
Cytotherapy|May 1, 2010
Vaccination with autologous dendritic cells pulsed with multiple tumor antigens for treatment of patients with malignant melanoma: results from a phase I/II trialRedas Trepiakas, Annika Berntsen, Sine Reker Hadrup, et al.
Cancer Research|August 4, 2004
Immunogenicity of constitutively active V599EBRafMads Hald Andersen, Joachim Fensterle, Selma Ugurel, et al.
Journal of Translational Medicine|August 23, 2012
Adoptive cell therapy with autologous tumor infiltrating lymphocytes and low-dose Interleukin-2 in metastatic melanoma patientsEva Ellebaek, Trine Zeeberg Iversen, Niels Junker, et al.
Cancer Immunology, Immunotherapy : CII|April 10, 2015
Data analysis as a source of variability of the HLA-peptide multimer assay: from manual gating to automated recognition of cell clustersCécile Gouttefangeas, Cliburn Chan, Sebastian Attig, et al.
Nature Methods|June 23, 2009
Parallel detection of antigen-specific T-cell responses by multidimensional encoding of MHC multimersSine Reker Hadrup, Arnold H Bakker, Chengyi J Shu, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 28, 2018
Peptide-MHC Class I Tetramers Can Fail To Detect Relevant Functional T Cell Clonotypes and Underestimate Antigen-Reactive T Cell PopulationsCristina Rius, Meriem Attaf, Katie Tungatt, et al.
Immunology|June 17, 2015
More tricks with tetramers: a practical guide to staining T cells with peptide-MHC multimersGarry Dolton, Katie Tungatt, Angharad Lloyd, et al.
Pageof 18

Showing results (131-140 of 171) with videos related to

Sort By:
Pageof 18
Oncoimmunology|July 14, 2025
ProS1-MerTK signaling in CD4 T cells: implications for TIL expansion and functionalityAnnina Kurzay, Sara Fresnillo Saló, Anne Rahbech, et al.
Oncoimmunology|May 8, 2015
Tryptophan 2,3-dioxygenase (TDO)-reactive T cells differ in their functional characteristics in health and cancerMads Duus Hjortsø, Stine Kiaer Larsen, Per Kongsted, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 24, 2016
Long-Lasting Complete Responses in Patients with Metastatic Melanoma after Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes and an Attenuated IL2 RegimenRikke Andersen, Marco Donia, Eva Ellebaek, et al.
Cytotherapy|May 1, 2010
Vaccination with autologous dendritic cells pulsed with multiple tumor antigens for treatment of patients with malignant melanoma: results from a phase I/II trialRedas Trepiakas, Annika Berntsen, Sine Reker Hadrup, et al.
Cancer Research|August 4, 2004
Immunogenicity of constitutively active V599EBRafMads Hald Andersen, Joachim Fensterle, Selma Ugurel, et al.
Journal of Translational Medicine|August 23, 2012
Adoptive cell therapy with autologous tumor infiltrating lymphocytes and low-dose Interleukin-2 in metastatic melanoma patientsEva Ellebaek, Trine Zeeberg Iversen, Niels Junker, et al.
Cancer Immunology, Immunotherapy : CII|April 10, 2015
Data analysis as a source of variability of the HLA-peptide multimer assay: from manual gating to automated recognition of cell clustersCécile Gouttefangeas, Cliburn Chan, Sebastian Attig, et al.
Nature Methods|June 23, 2009
Parallel detection of antigen-specific T-cell responses by multidimensional encoding of MHC multimersSine Reker Hadrup, Arnold H Bakker, Chengyi J Shu, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 28, 2018
Peptide-MHC Class I Tetramers Can Fail To Detect Relevant Functional T Cell Clonotypes and Underestimate Antigen-Reactive T Cell PopulationsCristina Rius, Meriem Attaf, Katie Tungatt, et al.
Immunology|June 17, 2015
More tricks with tetramers: a practical guide to staining T cells with peptide-MHC multimersGarry Dolton, Katie Tungatt, Angharad Lloyd, et al.
Pageof 18